{"id":56042,"date":"2026-01-13T19:54:21","date_gmt":"2026-01-13T19:54:21","guid":{"rendered":"https:\/\/www.parkinson.ca\/?page_id=56042"},"modified":"2026-04-08T17:16:02","modified_gmt":"2026-04-08T17:16:02","slug":"fonds-dinnovation-pour-la-recherche-kanta-marwah","status":"publish","type":"page","link":"https:\/\/www.parkinson.ca\/fr\/recherche\/recherche-financee\/fonds-dinnovation-pour-la-recherche-kanta-marwah\/","title":{"rendered":"Fonds d&rsquo;innovation pour la recherche Kanta Marwah"},"content":{"rendered":"\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Cr\u00e9\u00e9 au d\u00e9but de l\u2019ann\u00e9e 2025, le FIRKM soutient la recherche \u00e0 fort impact qui r\u00e9pond aux besoins essentiels non satisfaits des personnes atteintes de la maladie de Parkinson et contribue \u00e0 acc\u00e9l\u00e9rer les d\u00e9couvertes prometteuses, du laboratoire \u00e0 la clinique. Ce fonds a \u00e9t\u00e9 con\u00e7u pour \u00eatre flexible et r\u00e9actif, afin de soutenir des projets innovants qui font progresser de nouvelles approches th\u00e9rapeutiques, am\u00e9liorent le d\u00e9pistage pr\u00e9coce et renforcent les outils n\u00e9cessaires pour mieux pr\u00e9dire et traiter la maladie de Parkinson. Vous trouverez ci-dessous les projets soutenus \u00e0 ce jour par le FIRKM.<\/p>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading has-blue-color has-text-color has-link-color wp-elements-bbfbb4e420e1286dbd3e55763f615167\">Projets 2025:<\/h3>\n\n\n\n<p><strong>Dr Christopher Pack<\/strong> \u2013 <em>Universit\u00e9 McGill, Institut neurologique de Montr\u00e9al<\/em> <\/p>\n\n\n\n<p>Att\u00e9nuation des sympt\u00f4mes parkinsoniens par la stimulation c\u00e9r\u00e9brale non invasive <\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Dr Shady Rahayel<\/strong> \u2013 <em>Universit\u00e9 de Montr\u00e9al, Centre d\u2019\u00e9tudes avanc\u00e9es en m\u00e9decine du sommeil<\/em> <\/p>\n\n\n\n<p>Validation d\u2019une signature IRM bas\u00e9e sur la d\u00e9formation pour pr\u00e9dire la ph\u00e9noconversion dans le trouble isol\u00e9 du comportement en sommeil paradoxal (TICSP) <\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Dr Michael Schlossmacher<\/strong> \u2013 <em>Universit\u00e9 d\u2019Ottawa, Institut de recherche de l\u2019H\u00f4pital d\u2019Ottawa<\/em> <\/p>\n\n\n\n<p>Ajout de tests olfactifs \u00e0 l\u2019inventaire de C-OPN : Combler un vide pour mieux pr\u00e9dire la maladie de Parkinson incidente <\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading has-blue-color has-text-color has-link-color wp-elements-b6cc0fb319d8a04c53d12cb2c77835a7\">Financement ant\u00e9rieur : <\/h3>\n\n\n\n<p><strong>Dre Lorraine Kalia<\/strong> \u2013 <em>Universit\u00e9 de Toronto, R\u00e9seau universitaire de sant\u00e9<\/em> <\/p>\n\n\n\n<p>Peptides traversant la barri\u00e8re h\u00e9mato-enc\u00e9phalique pour le traitement de la maladie de Parkinson <\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cr\u00e9\u00e9 au d\u00e9but de l\u2019ann\u00e9e 2025, le FIRKM soutient la recherche \u00e0 fort impact qui r\u00e9pond aux besoins essentiels non satisfaits des personnes atteintes de la maladie de Parkinson et contribue \u00e0 acc\u00e9l\u00e9rer les d\u00e9couvertes prometteuses, du laboratoire \u00e0 la clinique. Ce fonds a \u00e9t\u00e9 con\u00e7u pour \u00eatre flexible et r\u00e9actif, afin de soutenir des [&hellip;]<\/p>\n","protected":false},"author":180,"featured_media":49131,"parent":50582,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-56042","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/pages\/56042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/users\/180"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/comments?post=56042"}],"version-history":[{"count":2,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/pages\/56042\/revisions"}],"predecessor-version":[{"id":58664,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/pages\/56042\/revisions\/58664"}],"up":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/pages\/50582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media\/49131"}],"wp:attachment":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media?parent=56042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}